These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 31877123)

  • 61. Natural disease history of the D2
    van Putten M; Putker K; Overzier M; Adamzek WA; Pasteuning-Vuhman S; Plomp JJ; Aartsma-Rus A
    FASEB J; 2019 Jul; 33(7):8110-8124. PubMed ID: 30933664
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mitochondrial content is preserved throughout disease progression in the mdx mouse model of Duchenne muscular dystrophy, regardless of taurine supplementation.
    Barker RG; Wyckelsma VL; Xu H; Murphy RM
    Am J Physiol Cell Physiol; 2018 Apr; 314(4):C483-C491. PubMed ID: 29351413
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Determination of qPCR Reference Genes Suitable for Normalizing Gene Expression in a Canine Model of Duchenne Muscular Dystrophy.
    Hildyard JCW; Taylor-Brown F; Massey C; Wells DJ; Piercy RJ
    J Neuromuscul Dis; 2018; 5(2):177-191. PubMed ID: 29614692
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
    van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
    Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Potential Therapeutic Action of Adiponectin in Duchenne Muscular Dystrophy.
    Abou-Samra M; Boursereau R; Lecompte S; Noel L; Brichard SM
    Am J Pathol; 2017 Jul; 187(7):1577-1585. PubMed ID: 28463682
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
    Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
    Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Morpholino-induced exon skipping stimulates cell-mediated and humoral responses to dystrophin in mdx mice.
    Vila MC; Novak JS; Benny Klimek M; Li N; Morales M; Fritz AG; Edwards K; Boehler JF; Hogarth MW; Kinder TB; Zhang A; Mazala D; Fiorillo AA; Douglas B; Chen YW; van den Anker J; Lu QL; Hathout Y; Hoffman EP; Partridge TA; Nagaraju K
    J Pathol; 2019 Jul; 248(3):339-351. PubMed ID: 30883742
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Localized treatment with a novel FDA-approved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-associated proteins in mdx mice.
    Bonuccelli G; Sotgia F; Capozza F; Gazzerro E; Minetti C; Lisanti MP
    Cell Cycle; 2007 May; 6(10):1242-8. PubMed ID: 17495527
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Photobiomodulation therapy protects skeletal muscle and improves muscular function of mdx mice in a dose-dependent manner through modulation of dystrophin.
    Albuquerque-Pontes GM; Casalechi HL; Tomazoni SS; Serra AJ; Ferreira CSB; Brito RBO; de Melo BL; Vanin AA; Monteiro KKDS; Dellê H; Frigo L; Marcos RL; de Carvalho PTC; Leal-Junior ECP
    Lasers Med Sci; 2018 May; 33(4):755-764. PubMed ID: 29209866
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Caspase-12 ablation preserves muscle function in the mdx mouse.
    Moorwood C; Barton ER
    Hum Mol Genet; 2014 Oct; 23(20):5325-41. PubMed ID: 24879640
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hemojuvelin is a novel suppressor for Duchenne muscular dystrophy and age-related muscle wasting.
    Zhang P; He J; Wang F; Gong J; Wang L; Wu Q; Li W; Liu H; Wang J; Zhang K; Li M; Huang X; Pu C; Li Y; Jiang F; Wang F; Min J; Chen X
    J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):557-573. PubMed ID: 30884219
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of the IL-1 Receptor Antagonist Kineret® on Disease Phenotype in mdx Mice.
    Benny Klimek ME; Sali A; Rayavarapu S; Van der Meulen JH; Nagaraju K
    PLoS One; 2016; 11(5):e0155944. PubMed ID: 27213537
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Melatonin improves muscle function of the dystrophic mdx5Cv mouse, a model for Duchenne muscular dystrophy.
    Hibaoui Y; Reutenauer-Patte J; Patthey-Vuadens O; Ruegg UT; Dorchies OM
    J Pineal Res; 2011 Sep; 51(2):163-71. PubMed ID: 21486366
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genetic ablation of P65 subunit of NF-κB in mdx mice to improve muscle physiological function.
    Yin X; Tang Y; Li J; Dzuricky AT; Pu C; Fu F; Wang B
    Muscle Nerve; 2017 Oct; 56(4):759-767. PubMed ID: 27997693
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nutraceutical and pharmaceutical cocktails did not improve muscle function or reduce histological damage in D2-mdx mice.
    Spaulding HR; Quindry T; Hammer K; Quindry JC; Selsby JT
    J Appl Physiol (1985); 2019 Oct; 127(4):1058-1066. PubMed ID: 31295065
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular hydrogen alleviates motor deficits and muscle degeneration in mdx mice.
    Hasegawa S; Ito M; Fukami M; Hashimoto M; Hirayama M; Ohno K
    Redox Rep; 2017 Jan; 22(1):26-34. PubMed ID: 26866650
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Growth Hormone Increases Bone Toughness and Decreases Muscle Inflammation in Glucocorticoid-Treated Mdx Mice, Model of Duchenne Muscular Dystrophy.
    Yoon SH; Grynpas MD; Mitchell J
    J Bone Miner Res; 2019 Aug; 34(8):1473-1486. PubMed ID: 31188496
    [TBL] [Abstract][Full Text] [Related]  

  • 79. D-Amino Acid Substitution of Peptide-Mediated NF-κB Suppression in mdx Mice Preserves Therapeutic Benefit in Skeletal Muscle, but Causes Kidney Toxicity.
    Reay DP; Bastacky SI; Wack KE; Stolz DB; Robbins PD; Clemens PR
    Mol Med; 2015 May; 21(1):442-52. PubMed ID: 26018805
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Restoration of pharyngeal dilator muscle force in dystrophin-deficient (mdx) mice following co-treatment with neutralizing interleukin-6 receptor antibodies and urocortin 2.
    Burns DP; Rowland J; Canavan L; Murphy KH; Brannock M; O'Malley D; O'Halloran KD; Edge D
    Exp Physiol; 2017 Sep; 102(9):1177-1193. PubMed ID: 28665499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.